Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Medicus Pharma Ltd. Common Stock
Market Cap
$10.10M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$10.18M
Gross Margin
0.00%
TTM Avg
44.31%
3Y Avg
60.00%
5Y Avg
55.54%
Market Cap
$9.97M
Gross Margin
-16431.82%
TTM Avg
-8215.91%
3Y Avg
-4057.95%
5Y Avg
-2671.97%
Market Cap
$9.92M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.79M
Gross Margin
-3767.20%
TTM Avg
-1960.46%
3Y Avg
-1022.20%
5Y Avg
-664.64%
Market Cap
$11.13M
Gross Margin
N/A
TTM Avg
-101.19%
3Y Avg
-33.23%
5Y Avg
-22.16%
Market Cap
$9.66M
Gross Margin
67.30%
TTM Avg
49.28%
3Y Avg
20.15%
5Y Avg
20.34%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.10M | 0.00% | 0.00% | 0.00% | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | 0.00% | 44.31% | 60.00% | 55.54% |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | 0.00% | 0.00% | 10.16% | 1.65% |
| Senti Biosciences, Inc. (SNTI)vs › | $9.97M | -16431.82% | -8215.91% | -4057.95% | -2671.97% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -3767.20% | -1960.46% | -1022.20% | -664.64% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.13M | N/A | -101.19% | -33.23% | -22.16% |
| Polyrizon Ltd. (PLRZ)vs › | $10.52M | N/A | 0.00% | 0.00% | 0.00% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | 67.30% | 49.28% | 20.15% | 20.34% |
| MetaVia Inc. (MTVA)vs › | $9.62M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
